A study suggests that lupus-like manifestations in patients with MDS/CMML frequently reflect clonal myeloid infiltration.
The Centers for Medicare & Medicaid Services has clarified steps providers must take to comply with Minimum Data Set requirements regarding incomplete or unsubmitted discharge assessments. Skilled ...
Adding venetoclax to oral decitabine-cedazuridine improves responses in higher-risk MDS and CMML patients. Inqovi, an oral decitabine-cedazuridine combination, was FDA approved in 2020 for primary or ...
Show More From the Department of Hematology and Medical Oncology, Moffitt Cancer Center and the University of South Florida, Tampa, FL; Department of Pathology and Immunology, Washington University ...
Myelodysplastic syndromes (MDS) affect the production of blood cells in your bone marrow. Survival rate and outlook with MDS depend on several risk factors. MDS is sometimes referred to as ...
Q: What are the concerns or consequences of dashing items on the MDS? A: Except for items using a dash-filled value to indicate an event has not yet occurred, i.e. the Medicare stay end date, a dash ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback